<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 144 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page143.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=144">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 144 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 144</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=144"><img src="../thumb/144.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>Cardio-Vascular Agents - 7.3.8 / 7.3.9                                         2020-04 / 113
       Side effects: Angioed., dry persist.cough, hepatit., elev.liv.enzym.,   Indications: Mild to mod.hypertens., adjunct.in CHF, within 24 hrs.  Dosage: Recomm.dos: 20 mg or 40 mg once dly. Max: 80 mg once
       syndr.start.with cholestat. jaund.progress.to hepat.necros.somet.  aft.ac.MI in haemodynamic. stable pts.  dly. May be used in combin.with low dos. thiaz.diuret. Max.antihy-
       death, sens. reacts.with/without allergy/bronch.asthma hist., ex-  (S3) TABS. V/7.1.3/160, 161, 162.  pertens.eff.is gen. attain.4-8 wks.aft.start of treatm.
       acerbat./activat. SLE, hyperuricaem., hypomagnesaem, myocard.is-  781681-006: 5 mg, 30, R41,69  Mild to mod.hepat.impair: Do not exceed 40 mg once dly.
       chaem. incl.ang.pect., bld.disords., headache, dizzin., vertigo, paraes-  781703-018: 10 mg, 30, R41,69  Contraindications: Angioed.hist.link.to prev.ACE inhibit./angiotens.
       thes., tremor, CNS effs., lightheadedn., neuralg., vis./taste disturbs.,   781711-002: 20 mg, 30, R78,86  recept.blocks., heredit./idiopath. angioed., hypertroph.obstruct.cardio-
       tinnit., bronchit., sinusit., dyspn., nas.congest., GI disturbs., gingivit.,   Dosage: Mild to mod.hypertens: Init.10 mg with usual   myopathy, sev. ren. impairm., bil.ren.artery stenos., ren.artery stenos.
       stomatit., dry mouth, ren.impairm.incl.ac. ren.fail., incr.urine output,   maint.20 mg/day as sngl.dos. Max. 40 mg/ day. Pts.on diuret: Init.   to sngl.kidn., aort.stenos., bil.obstruct. disords., sev.hepat.impairm.,
                                                                        +
       skin reacts.incl.tox. epiderm.necrolys./Stev.Johns.syndr./erythema   5 mg/day then adjust accord. to respons. May be incr.at 2-4wk interv.  concom.Li/K spar. diurets., porphyr., pregn.& lactat., concom.renin
       multiforme, alopec., back/chest pain, arthralg., myalg., metabol.  if desir. respons.not achiev.  inhibit.eg aliskrien-contain.products.
       disords. incl.electrol.imbal./ glycosur./metabol alkalos., gout ag-  CHF: Pts.not adeq.contr.by digital.and/or diuret: Init. 2,5 mg once a   Side effects: Less.freq: UTI, URTI, bld.dyscras., hypersens., angi-
       grav., incr.bld. cholestr.&/triglycerid., anorex., thirst, syncope, flush.,   day. Usual effect.dos.range is 5-20 mg/ day.admin.as sngl.dly.dos.   oed., hyperkalaem., hypoglycaem., anx.,depress., insomn., syncope,
       orthostat.hypotens., fatig., asthen., pyrex., impot, psych.disords.,   May be incr.at 4wk. interv.when addit.eff.reqd.upto max.35 mg/ day  faint., somnol., abnorm.vis., vertigo, tachycard., bradycard., hypotens.,
       tachycard., palpitat., card. dysrhythm., ischaem.stroke, periph./non-  Acute MI: Start treatm.within 24 hrs.of sympt. onset. Init. 5 mg,   cough, dyspn., GI disords.,abnorm. hepat. funct., liv.disord., hyperhi-
       cardiog. pulm.oed., cerebr.ischaem., TIA, weakn., xanthops., decr.  follow.by 5 mg aft. 24 hrs., 10 mg aft. 48 hrs.& then 10 mg once dly.   dros., erythema, prurit., eczema, rash, drug erupt., tox.skin erupt., ar-
       lacrimat., imp.hear., bronchosp. incl. asthma aggravat., allerg.alve-  In case of hypotens. admin.5 mg dly.as maint.dos.reduc. tempor. to   thralg., myalg., back pain, musc.cramp, extremity pain, ren.impairm.
       olit., pancreatit., sialoadenit., worsen.of pre-exist.proteinur., interstit.   2,5 mg if necess. Cont.for 6 wks.  incl.ac.ren.fail., chest pain, flu-like sympt., asthen. Unknown freq:
       nephrit., photosens., onycholys., musc. cramp/spasm/stiffn., tetany,   Contraindications: Pregn.& nursing mothers, heredit./idiopath.  Sepsis incl. fatalit., eosinophil., anaphylact.react., urticar., tendon pain.
       hypercalcaem., vasc. disords.incl.Raynaud’s phenom., anaphylact.   angioed., aortic.stenos./ hypertroph. cardiomyopathy  Warnings and special precautions: Stop. treatm. & chang.if
       reacts., decr.libido, gynaecomast.  Side effects: Dizz., headache, diarrh., fatig., N&V, cough, orthostat.  pregn.occurs/plan., incr.sev. hypotens. & ren.insuff.risk with bil.ren.
       Special precautions: Limit.exper.in elderly &gt;65 yrs, no re-challenge   eff., rash, asthen., hypersens. reacts., palpit., tachycard., abdom.pain,   artery stenos./ren.artery stenos.to sngl.funct.kidn., per.monit.K /cre-
                                                                                            +
       aft.angioed.react., cross. placenta, excret.in breast milk, monit.infts.  indigest., dry mouth, hepatit., jaund., pancreatit., mood alterat., ment.  atin.lev.of risk pts., no exper.in ren.transplant., vol./Na deplet.to be
       expos. to ther.in utero, stop.ther.& switch.to diff.class. meds.in case   confus., paraesthes., vertigo, taste & sleep disturbs., bronchosp.,   correct.bef. init. ther., dual block.of renin angiotens.-aldosterone syst.
       of pregn./contempl.pregn., women of childbear.age, discont.ther.in   rhinit., sinusit., urticar., diaphores., alopec., prurit., psorias.& sev.skin   (RAAS) incr.hypotens./ hyperkalaem. & decr.ren.funct.risk, pts.where
       case of angioed., high. incid.of angioed.in black pts., angioed. hist.   disords., uraemia, oligur./anuria, ren. dysfunct., ac. ren. fail., impot.,   vasc. tone & ren.funct.depend predomin.on RAAS activ., not recomm.
       unrelat.to ACE inhib.ther.poss.incr.risk, decr. coron. perfus.risk in pts.  sympt.complex, photosens., bld. dyscras.incl.bone marr.depress.,   in prim.aldosteronism, concom. K spar. diuret./K supplem.or salt
                                                                                       +
                                                                                 +
       with aort.stenos., diet.salt restrict., dialys., N&V, diarrh., sod./vol.de-  agranulocyt.& haemolyt. anaem., hyperkalaem., hyponatraem., hy-  substit.contain. K / meds.poss.incr.ser.K  lead.to incr.ser.K not to be
                                                                          +
                                                                                          +
                                                                                   +
       plet.& correct bef.init.ther., MI & CVA second.to excess. hypotens. in   poglycaem., hepat.fail.  admin.concom., bil.obstruct.disords./mild to mod. hepat. insuff., less
       high risk pts., discont.ther.if syncope occurs, per.white bld.cell monit.,   Special precautions: Symptom.hypotens.in vol. depl. pts.& CCF   eff.in low.BP in black people, excess.BP reduct.in ischaem. Cardiopa-
       pts.to report any infect.S&S, poss.anaphylact.reacts in haemodialys.   with/without ren insuffic., poss. MI/ CVA with ischaem.heart/ cer-  thy /ischaem.card.vasc.dis.may result in MI/stroke, adeq. contracept.
       proced.using high-flux membran.& dur. desensitisat., discont.ther.if   ebrovasc.dis., imp. ren.funct., ren.artery stenos., concom.diuret., an-  in women of childbear.age, safety & effic.in childr.und.18 yrs.not est.
       jaund./mark. hepat. enzym.elevat.occur, viral-like/unexpl. sympt. dur.  aphylact. reacts.in dialys.pts.receiv. ACE inhibits. /dur.desensitisat.  Drug interactions: High.advers.reacts.& decr. ren.funct.with dual
       init.ther., electrol/fluid imbal., ac.gout precipit., incr.Mg excret., decr.  treatm., maj.surg./dur. anaeasth., incr.angio-oed risk in angio-oed.  block.of RAAS with ARB’s/ACE inhibit or renin inhibit., incr.eff.of
       urin.Ca excret., maj. surg./anaesth., Li toxic. sympt., avoid alcoh.  hist. unrelat. to ACE inhibit.& in black pts., diab.  other antihypertens., baclofen/amifostine/alcoh./ barbitur./ narcot.
       esp. init., admin.ther.at least one hr.bef.cholestyramine /cholestipol,   Drug interactions: Diuret.potent.act., indomethacin dimin.act.,   & antidepress.poss.potent. hypotens. effs., incr.digox.plasma conc.,
       manifestat.of latent diab.mellit., electrol./ bld.gluc.monit., ren.funct.  furth.deteriorat.in ren. funct. of pts.with comprom.ren.funct.receiv.   incr.ser.Li conc. & toxic., K spar. diuret./K supplem.or salt substit.
                                                                              +
                                                                                    +
           +
       monit., K -cont. salt subst., electrol.monit.with digoxin, monit.pt.   NSAID’s, Li-elim.dimin., K-supplem., K-spar.diuret. /K-contain. salts   contain. K lead.to incr.ser.K , NSAID’s incr.ac.ren.impairm.risk in de-
                                                                              +
                                                                       +
       weight/diuret.eff. with NSAID.  partic.in ren.dysfunct.may incr. ser. K.  hydrat., vol.deplet.& hypotens.risk with diuret.meds., reduc.antihy-
       Drug interactions: Addit.eff.with other antihypertens., K -supplem./  pertens.eff.with corticoster.
                              +
       K -spar.diuret./ K -cont.salts incr.serum K , incr.ser. Li lev., poss.incr.
        +
              +
                        +
       digoxin toxic.risk with thiazide-induc.electrolyte disturbs., NSAID’s   ADCO-VALSARTAN, AI Pharm Ltd [P/S]
       decr.diuret./natriuret./ antihypertens. effic., poss.reduc.insul.resist.,  7.3.9   Angiotensin receptor   Valsartan
       bld. gluc. low.effs.of hypoglycaem.agents potent., effs. of non-depolar.  Indications: Mild to mod.hypertens., HF(NYHA class 11-1V), improv.
       skelet.musc.relax.enhanc., decr. respons.to sympathomimet.agents,   antagonists  surviv.foll.MI in clinic.stable pts. with S&S/radiolog.evid.of left ventr.
       alcoh./barbits. & narcot.may potent.orthostat.hypotens., corticoster.   fail.&/left ventr. syst.dysfunct.
       & ACTH intens.electrol.deplet.& hypokalaem., hydrochlorothiaz.ab-  CO-EXFORGE (MDR Listing)  (S3) TABS. 44/7.1.3/0521, 0522
       sorpt.reduc.by cholestyramine/ colestipol resins, enhanc.K-depl. eff.   CO-PRITOR (MDR Listing)  723946-001: 80 mg, 30, R125,63
       with beta 2-agonists, incr.responsiv.to tubocurar.  EXFORGE (MDR Listing)  723947-001: 160 mg, 30, R125,63
                                     TWYNSTA (MDR Listing)
       ZANERIL, Litha Pharma (Pty) Ltd                            Dosage: Hypertens: Recomm.dos: 80 mg or 160 mg once dly.
                                                                  Subst. eff.pres.with.2 wks.& max. eff.aft. 4 wks. Dos.incr.to 320 mg
       See Section 7.3.7             ABECARD, (Forrester) Lasara [P/S]  dly.or diuret. add. in pts.not adeq.control. May be admin. with other
                                     Candesartan cilexetil
       ZESTORETIC, AstraZeneca       Indications: Mild to mod.hypertens.as monother./ concom. with   antihypertens.agents.
       Lisinopril as dihydrate 10(20)mg, hydrochlorothiazide 12,5 mg.  other antihypertens., reduc.mortal.& hospitalisat.due to HF & improv.  Post MI: May be init.as early as 12 hrs aft.MI in clinic.stab.pts. Aft.
       Indications: Mild to mod.hypertens.in pts. stabilis. on their indiv.  sympts.in L ventr. systol.dysfunct (LVEF &lt;40%)  init dos. of 20 mg 2x dly., ther.to be titrat.to 40 mg, 80 mg & 160 mg
       compon.in same proport.       (S3) TABS, 46/7.1.3/0231, 0232, 0233  2x dly over next few wks. Start.dos provid.by 40 mg scor.tabl. Targ.
       (S3) TABS. 29/7.1.3/0652, 27/7.1.3/0366  721629-001: 8 mg, 30, R143,12  dos: 160 mg 2x dly. Dos. lev.of 80 mg 2x dly. to be achiev.by 2 wks.
       817848-002: 10/12,5 mg, 30, R55,66  721630-001: 16 mg, 30, R143,12  aft.init.& targ.max.dos.by 3 mnths. depend.on.toler.dur.titrat. Cons.
       797685-006: 20/12,5 mg, 30, R94,62  721631-001: 32 mg, 30, R143,12  dos. reduct. should sympt.hypotens./ren.dysfunct. occur.
       Dosage: Essent.hypertens: 1 tab once dly. Max 2 tabs once dly.  Dosage: Hypertens: Recomm.init.dos.: 8 mg once dly. Usual   Heart fail: Recomm.dos: 40 mg 2x dly. Up-titrat.to 80 mg & 160 mg
       Contraindications: Anur., hist.of angioneurot. oed. with ACE-in-  maint: 8-16 mg once dly. Max. antihypertens. eff.within 4 wks. Dos.  2xdly to be done to high.dos.toler. Dos.reduct.of concom.diurets.
       hibit., heredit./idiopath.angioed., pregn. & lactat., sulphonam.sens.,   may be incr. to max.32 mg once dly.  may be cons.
       aortic.stenos./ hypertroph. cardiomyopathy  Heart fail: Recomm.init.dos: 4 mg once dly. with target dos.of   Contraindications: Angioed hist. relat.to prev. ther.with ACE-inhib-
       Side effects: Dizzin., fatig., headache, dry cough/ mouth, hypo-  32 mg once dly.achiev. by doubl.dos. at approx. 2 wk.interv.as toler.   its./angiotens. recept.blocks, heredit./idiopath.angioed., hypertroph.
       tens., GI disturbs., rash, gout, palpitat., chest discomf., musc.cramps   May be admin in combinat. with other CF treatm.  obstruct. cardiomyopathy, sev.liv.fail./bil.cirrhos./ cholestas., sev.ren.
       & weakn., paraesthes., asthen., impot., bld.disords., bone marr.   Contraindications: Angioed.hist. relat.to prev. ther. with ACE inhibits./  impairm.& dialys.pts., bil.ren. artery stenos., ren.artery stenos.with
                                                                                 +
       depress., hyperglycaem., hypo/hyperkalaem., hyperuricaem., pan-  angiotens.recept.blocks., heredit./ idiopath.angioed., hypertroph.obstruct.   sngl.kidn., aort. stenos., concom.K  spar.diurets., porphyr., Li-ther.,
       creatit., intestin.angioed., hepatit., hepat.fail., jaund., angioneurot.  cardiomyopathy, sev.ren.funct.impairm., bilat.ren. art. stenos./ stenos.in   safety in pregn.& lactat.not est.
                                                     +
       oed., sympt. complex, fev., vasculit., myalg., arthralg/ arthrit., pho-  pres.of sngl.kidn., aort. stenos., concom.K  spar.diurets., porphyr., Li-ther.,   Side effects: Vir.infects., URTI, bld.dyscras., hypersens. incl. ser.
       tosens., sialoadenit., vertigo, xanthops., urticar.,resp. distress.incl.  safety in pregn.& lactat.not est., safety & effic. in childr. not est.  sickn.& angioed., psych./eye / GI disords., decr.libido, dizzin., neu-
       pneumonit./ pulm. oed./pulm.infiltrates, sensitiv./anaphylact. re-  Side effects: Resp.infects., bld.dyscras., angioed., hyperkalaem.,   ralg., headache, CNS effs., conjunctivit., CF, orthostat.hypotens.,
       acts., glycosur., electrol.imbal.incl.hyponatraem., restlessn., trans.  hyponatraem., dizzin., headache, vertigo, ang.pect., MI, hypotens.,   vasculit., haemorrh., cough., epistax., skin reacts., back/ musc.pain,
       blurr.vis., ren.fail./dysfunct., interstit. nephrit., MI & CVA second.to   pharyngit., rhinit., URTI, cough, naus., abnorm. hepat.funct., incr.liv.  musc.cramps, arthrit., arthralg., kidn. dysfunct., ac.ren.fail., fatig.,
       excess. hypotens. in high risk pts., tachycard., mood alterat., ment.   enzym., hepatit., skin reacts., hyperuricaem., gout, back pain, arthralg.,   asthen., oed., elev.LFT.
       confus., taste/sleep disturbs., bronchosp., rhinit., sinusit., diaphores.,   myalg., ren.impairm.incl.ren.fail.  Special precautions: No re-challege.aft. angioed. react., adeq.
       alopec., prurit., psorias.& sev.skin disords.incl.pemphigus/ toxic epi-  Warnings and special precautions: No re-challenge in case of angi-  contracept.in women of childbear. potent., hyperkalaem., ther.to
       derm.necrolys./Stevens-Johnson syndr.& erythema multiforme, hy-  oed. hist.relat.to prev.ACE inhibits./ ARB ther., stop ther.& switch to diff.   be stopp. & switch.to anoth.class of antihypertens.meds.if pregn.
       poaesthes., uraem./ oligur. & anur., may precipit.exacerb./activ.SLE,   antihypertens. if a woman becom.pregn., discont. ther. if pregn. plann./  confirm./plann., symptomat.hypotens.poss occur in sod.&/ vol.de-
       gluc. tol.poss.impair., urin.Ca excret.decr., incr. triglycerid./ cholestr.  confirm., adeq.contracept. in women of childbear.potent., excret.in milk   plet.pts.such as those receiv. high diuret.dos.&/in mod.or sev.ren
       Special precautions: Monit.ser.K.freq., vol/salt deplet. pts., init.  of lactat. rats, monit.ser.Li-lev., no exper.in recent kidn. transpl., anaes-  impairm., Na &/vol.deplet.correct.bef.init.ther., monit.ser. K conc.
                                                                                            +
       ther.in ren.insuffic., if poss. discont. diuret.2-3 day bef.start.treatm.,   thes./ surg., HF, correct intravasc. vol.deplet.bef.init.ther., bil./sngl.ren.  esp.elderly with ren.impairm., hepat. impairm. hist., post-MI, where
       symptomat. hypotens., fluid/electrol.imbal., ischaem. heart dis.,   art. stenos., monit.ser.K  & creatin.lev.in ren. impairm. /dur. dos.titrat.,   ren.funct. depend. on renin-angiotens.-aldost.syst., incr. mortalit. in
                                              +
       cerebrovasc.dis., discont.if incr. bld.urea & serum creatinine occur   elderly, mod.hepat.impairm., no exper. in sev.hepat.impairm.&/choles-  HF with concom.ACE inhib./beta-block., ren.funct. monit.in post-MI
       with no appar. pre-exist.ren.dis., maj.surg./anaesth., anaphylactoid   tas., Li-toxic., antihypertens.eff.less in black pts., ren.-angiotens.-aldost.  & HF, not indic.for childr.& adolesc.
       reacts.exper.in concom. haemodialys. proced.using high-flux mem-  syst.activ., excess.BP decr.in ischaem. cardiopathy/CV dis.poss.result in   Drug interactions: Tox.bld.conc.with concom.Li, antihypertens.eff.
                                             +
       bran. AN 69 & densensitisat.treatm., imp.hepat.funct./ progress. liv.  MI/ stroke, per.ser.K lev.monit.in HF where concom. ACE-inhib./K -spar.  antagon.by NSAID’s, antihypertens. eff.poss.reduc.with sympathom-
                                                              +
       dis., angioneurot.oed.hist., safety in childr. not est., concom.K-sup-  diuret.not recomm., lact.intol.  imet., incr.ser.K  lev with K  spar. diurets./ K  supplem./K salt substit.
                                                                             +
                                                                         +
                                                                                    +
                                                                                         +
       plem., K-spar./ contain. agents, poss.dos.adjustm.of anti-diab. meds.  Drug interactions: Antihypertens.eff.enhanc.by other antihypertens.,
       Drug interactions: K -supplem., K -spar.diuret./ K -contain.salts   add.hypotens.eff.with diurets., incr.ser.K  with K -spar.diurets./K -sup-  AMZAAR, MSD
                 +
                       +
                                                        +
                                                     +
                             +
                                                              +
       partic.with ren.impairm.may incr. ser. K , Li clear.reduc., addit.eff.with   plem./ K -contain.salt substit./other drugs incr. K -lev., incr.ser.Li lev./toxic.  Amlodipine 5(5) mg, losartan 50(100) mg.
                                        +
                       +
                                                       +
       other anti-hypertens. agents, indomethac.may dimin. antihypertens.   Indications: Essent.hypertens.in pts.stabilis.on same dos.of in-
       effic., furth.deteriorat.in ren.funct. of pts.with comprom.ren.funct.re-  ADCO-TELMISARTAN, AI Pharm [P/S]  div.compon.
       ceiv NSAID’s, incr. responsiven.to tubocurar.,alcoh., barbits.& narcot.   Telmisartan  (S3) TABS. 46/7.1.3/0559, 0560
       may potent.orthostat.hypotens., corticoster. & ACTH intens.electrol.  Indications: Mild to mod.hypertens.alone/ combin. with hydro-  3000160-001: 5/50 mg, 30, R210,37
       deplet., NSAID may reduc. eff., poss.decr.respons.to press.amines.  chlorothiazide.  3000161-001: 5/100 mg, 30, R210,37
                                     (S3) TABS, 46/7.1.3/0248, 0249  Dosage: May be admin.with other class.of antihypertens.meds.
       ZESTRIL, AstraZeneca [P/S]    3000736-001: 40 mg, 30, R142,49  Recomm.dos: 1 tab./day. Usual dos: 5/50 mg dly. Max. dose:
       Lisinopril dihydrate.         3000737-001: 80 mg, 30, R142,49  5/100 mg dly</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page143.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page139.html">139</a>&nbsp;&nbsp;&nbsp;<a href="page140.html">140</a>&nbsp;&nbsp;&nbsp;<a href="page141.html">141</a>&nbsp;&nbsp;&nbsp;<a href="page142.html">142</a>&nbsp;&nbsp;&nbsp;<a href="page143.html">143</a>&nbsp;&nbsp;&nbsp;<a href="page144.html">144</a>&nbsp;&nbsp;&nbsp;<a href="page145.html">145</a>&nbsp;&nbsp;&nbsp;<a href="page146.html">146</a>&nbsp;&nbsp;&nbsp;<a href="page147.html">147</a>&nbsp;&nbsp;&nbsp;<a href="page148.html">148</a>&nbsp;&nbsp;&nbsp;<a href="page149.html">149</a>
             </td>
             <td width="35%"><a href="page145.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page145.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
